CVI Investments, Inc. 13D and 13G filings for Phio Pharmaceuticals Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 2:49 pm Purchase | 2025-12-31 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | CVI Investments, Inc. | 1,194,719 9.900% | 461,375 (+62.91%) | Filing |
| 2025-11-10 6:36 pm Purchase | 2025-11-03 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | CVI Investments, Inc. | 733,344 9.900% | 642,356 (+705.98%) | Filing |
| 2025-02-07 4:09 pm Sale | 2024-12-31 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | CVI Investments, Inc. | 90,988 4.900% | -18,310 (-16.75%) | Filing |
| 2024-12-26 2:19 pm Purchase | 2024-12-19 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | CVI Investments, Inc. | 109,298 7.300% | 107,179 (+5058.00%) | Filing |